Abstract
We previously developed a quantitative system for the detection of cytokeratin 19 (CK-19) transcripts using reverse transcriptase polymerase chain reaction (PCR) to detect breast carcinoma cells in blood and bone marrow. The aim of this study was to determine the value of this system in monitoring patients with metastatic disease and to compare it with an established immunocytochemical method.
Original language | English |
---|---|
Pages (from-to) | 1432-1439 |
Number of pages | 8 |
Journal | Journal of Clinical Oncology |
Volume | 18 |
Issue number | 7 |
Publication status | Published - Apr 2000 |